nodes	percent_of_prediction	percent_of_DWPC	metapath
Letrozole—CYP2A6—Tretinoin—peripheral nervous system neoplasm	0.322	0.607	CbGbCtD
Letrozole—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0693	0.13	CbGbCtD
Letrozole—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0644	0.121	CbGbCtD
Letrozole—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0296	0.0557	CbGbCtD
Letrozole—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0271	0.051	CbGbCtD
Letrozole—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0185	0.0348	CbGbCtD
Letrozole—Constipation—Vincristine—peripheral nervous system neoplasm	0.000282	0.000602	CcSEcCtD
Letrozole—Pain in extremity—Doxorubicin—peripheral nervous system neoplasm	0.000282	0.000602	CcSEcCtD
Letrozole—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000282	0.000602	CcSEcCtD
Letrozole—Rash—Melphalan—peripheral nervous system neoplasm	0.000281	0.0006	CcSEcCtD
Letrozole—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000281	0.000599	CcSEcCtD
Letrozole—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00028	0.000597	CcSEcCtD
Letrozole—Dry skin—Epirubicin—peripheral nervous system neoplasm	0.00028	0.000596	CcSEcCtD
Letrozole—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000279	0.000595	CcSEcCtD
Letrozole—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000278	0.000593	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000277	0.000591	CcSEcCtD
Letrozole—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000276	0.000588	CcSEcCtD
Letrozole—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.000276	0.000588	CcSEcCtD
Letrozole—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.000275	0.000585	CcSEcCtD
Letrozole—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000272	0.00058	CcSEcCtD
Letrozole—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000271	0.000577	CcSEcCtD
Letrozole—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000271	0.000577	CcSEcCtD
Letrozole—Nausea—Topotecan—peripheral nervous system neoplasm	0.000271	0.000577	CcSEcCtD
Letrozole—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.00027	0.000575	CcSEcCtD
Letrozole—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000268	0.000572	CcSEcCtD
Letrozole—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000268	0.000572	CcSEcCtD
Letrozole—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000267	0.00057	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000266	0.000567	CcSEcCtD
Letrozole—Infection—Etoposide—peripheral nervous system neoplasm	0.000266	0.000566	CcSEcCtD
Letrozole—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000265	0.000565	CcSEcCtD
Letrozole—Nausea—Melphalan—peripheral nervous system neoplasm	0.000265	0.000565	CcSEcCtD
Letrozole—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000264	0.000562	CcSEcCtD
Letrozole—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000262	0.000559	CcSEcCtD
Letrozole—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000261	0.000556	CcSEcCtD
Letrozole—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000261	0.000556	CcSEcCtD
Letrozole—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000261	0.000556	CcSEcCtD
Letrozole—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.00026	0.000555	CcSEcCtD
Letrozole—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.00026	0.000554	CcSEcCtD
Letrozole—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.000259	0.000551	CcSEcCtD
Letrozole—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000258	0.000551	CcSEcCtD
Letrozole—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000257	0.000547	CcSEcCtD
Letrozole—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000255	0.000544	CcSEcCtD
Letrozole—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000255	0.000543	CcSEcCtD
Letrozole—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.000254	0.000542	CcSEcCtD
Letrozole—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000254	0.000541	CcSEcCtD
Letrozole—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000253	0.000539	CcSEcCtD
Letrozole—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000252	0.000537	CcSEcCtD
Letrozole—Pain—Cisplatin—peripheral nervous system neoplasm	0.00025	0.000532	CcSEcCtD
Letrozole—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000246	0.000524	CcSEcCtD
Letrozole—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000244	0.00052	CcSEcCtD
Letrozole—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000243	0.000519	CcSEcCtD
Letrozole—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000242	0.000517	CcSEcCtD
Letrozole—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00024	0.000513	CcSEcCtD
Letrozole—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.00024	0.000512	CcSEcCtD
Letrozole—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.00024	0.000511	CcSEcCtD
Letrozole—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000238	0.000508	CcSEcCtD
Letrozole—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000238	0.000508	CcSEcCtD
Letrozole—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000238	0.000507	CcSEcCtD
Letrozole—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000238	0.000507	CcSEcCtD
Letrozole—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000237	0.000505	CcSEcCtD
Letrozole—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000235	0.000501	CcSEcCtD
Letrozole—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000235	0.000501	CcSEcCtD
Letrozole—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000235	0.000501	CcSEcCtD
Letrozole—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000234	0.0005	CcSEcCtD
Letrozole—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000233	0.000497	CcSEcCtD
Letrozole—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000232	0.000496	CcSEcCtD
Letrozole—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000231	0.000492	CcSEcCtD
Letrozole—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000231	0.000492	CcSEcCtD
Letrozole—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000231	0.000492	CcSEcCtD
Letrozole—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000229	0.000488	CcSEcCtD
Letrozole—Pain—Etoposide—peripheral nervous system neoplasm	0.000229	0.000488	CcSEcCtD
Letrozole—Constipation—Etoposide—peripheral nervous system neoplasm	0.000229	0.000488	CcSEcCtD
Letrozole—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000228	0.000487	CcSEcCtD
Letrozole—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000227	0.000483	CcSEcCtD
Letrozole—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000226	0.000482	CcSEcCtD
Letrozole—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000225	0.00048	CcSEcCtD
Letrozole—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000225	0.00048	CcSEcCtD
Letrozole—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000222	0.000474	CcSEcCtD
Letrozole—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000222	0.000473	CcSEcCtD
Letrozole—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000221	0.00047	CcSEcCtD
Letrozole—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.00022	0.00047	CcSEcCtD
Letrozole—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000219	0.000468	CcSEcCtD
Letrozole—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000219	0.000466	CcSEcCtD
Letrozole—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000218	0.000465	CcSEcCtD
Letrozole—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000218	0.000464	CcSEcCtD
Letrozole—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000217	0.000464	CcSEcCtD
Letrozole—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000217	0.000464	CcSEcCtD
Letrozole—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000216	0.000461	CcSEcCtD
Letrozole—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000216	0.00046	CcSEcCtD
Letrozole—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000215	0.000458	CcSEcCtD
Letrozole—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000212	0.000453	CcSEcCtD
Letrozole—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000212	0.000452	CcSEcCtD
Letrozole—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000212	0.000452	CcSEcCtD
Letrozole—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000211	0.000451	CcSEcCtD
Letrozole—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000211	0.000451	CcSEcCtD
Letrozole—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000211	0.000451	CcSEcCtD
Letrozole—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000211	0.00045	CcSEcCtD
Letrozole—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000211	0.00045	CcSEcCtD
Letrozole—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.00021	0.000448	CcSEcCtD
Letrozole—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00021	0.000447	CcSEcCtD
Letrozole—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000209	0.000446	CcSEcCtD
Letrozole—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.000444	CcSEcCtD
Letrozole—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000208	0.000444	CcSEcCtD
Letrozole—Rash—Vincristine—peripheral nervous system neoplasm	0.000208	0.000444	CcSEcCtD
Letrozole—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000208	0.000443	CcSEcCtD
Letrozole—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000208	0.000443	CcSEcCtD
Letrozole—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000207	0.000442	CcSEcCtD
Letrozole—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000207	0.000441	CcSEcCtD
Letrozole—Headache—Vincristine—peripheral nervous system neoplasm	0.000207	0.000441	CcSEcCtD
Letrozole—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.000438	CcSEcCtD
Letrozole—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000203	0.000434	CcSEcCtD
Letrozole—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.0002	0.000426	CcSEcCtD
Letrozole—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000199	0.000425	CcSEcCtD
Letrozole—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000197	0.00042	CcSEcCtD
Letrozole—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000196	0.000418	CcSEcCtD
Letrozole—Nausea—Vincristine—peripheral nervous system neoplasm	0.000196	0.000418	CcSEcCtD
Letrozole—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000196	0.000417	CcSEcCtD
Letrozole—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000196	0.000417	CcSEcCtD
Letrozole—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.000416	CcSEcCtD
Letrozole—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.000416	CcSEcCtD
Letrozole—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000194	0.000414	CcSEcCtD
Letrozole—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000193	0.000411	CcSEcCtD
Letrozole—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000192	0.00041	CcSEcCtD
Letrozole—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000192	0.000409	CcSEcCtD
Letrozole—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000192	0.000409	CcSEcCtD
Letrozole—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000191	0.000408	CcSEcCtD
Letrozole—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000191	0.000408	CcSEcCtD
Letrozole—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.00019	0.000405	CcSEcCtD
Letrozole—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000189	0.000403	CcSEcCtD
Letrozole—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000186	0.000397	CcSEcCtD
Letrozole—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000186	0.000396	CcSEcCtD
Letrozole—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000185	0.000394	CcSEcCtD
Letrozole—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000185	0.000394	CcSEcCtD
Letrozole—Rash—Cisplatin—peripheral nervous system neoplasm	0.000184	0.000392	CcSEcCtD
Letrozole—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000184	0.000392	CcSEcCtD
Letrozole—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000184	0.000392	CcSEcCtD
Letrozole—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000183	0.00039	CcSEcCtD
Letrozole—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000389	CcSEcCtD
Letrozole—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000386	CcSEcCtD
Letrozole—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000386	CcSEcCtD
Letrozole—Tension—Epirubicin—peripheral nervous system neoplasm	0.00018	0.000384	CcSEcCtD
Letrozole—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.00018	0.000383	CcSEcCtD
Letrozole—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000178	0.00038	CcSEcCtD
Letrozole—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000178	0.000379	CcSEcCtD
Letrozole—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000177	0.000378	CcSEcCtD
Letrozole—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000177	0.000377	CcSEcCtD
Letrozole—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000176	0.000375	CcSEcCtD
Letrozole—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000173	0.00037	CcSEcCtD
Letrozole—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000173	0.000369	CcSEcCtD
Letrozole—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.000368	CcSEcCtD
Letrozole—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000365	CcSEcCtD
Letrozole—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.00017	0.000363	CcSEcCtD
Letrozole—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00017	0.000362	CcSEcCtD
Letrozole—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.000362	CcSEcCtD
Letrozole—Rash—Etoposide—peripheral nervous system neoplasm	0.000169	0.000359	CcSEcCtD
Letrozole—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000168	0.000359	CcSEcCtD
Letrozole—Headache—Etoposide—peripheral nervous system neoplasm	0.000167	0.000357	CcSEcCtD
Letrozole—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000356	CcSEcCtD
Letrozole—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.000355	CcSEcCtD
Letrozole—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000166	0.000353	CcSEcCtD
Letrozole—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.000352	CcSEcCtD
Letrozole—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000165	0.000352	CcSEcCtD
Letrozole—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000164	0.00035	CcSEcCtD
Letrozole—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.00035	CcSEcCtD
Letrozole—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000162	0.000346	CcSEcCtD
Letrozole—Cough—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000342	CcSEcCtD
Letrozole—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.000341	CcSEcCtD
Letrozole—Nausea—Etoposide—peripheral nervous system neoplasm	0.000159	0.000339	CcSEcCtD
Letrozole—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000159	0.000338	CcSEcCtD
Letrozole—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.000336	CcSEcCtD
Letrozole—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000156	0.000333	CcSEcCtD
Letrozole—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000156	0.000333	CcSEcCtD
Letrozole—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000156	0.000333	CcSEcCtD
Letrozole—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000156	0.000332	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000155	0.000331	CcSEcCtD
Letrozole—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000154	0.000329	CcSEcCtD
Letrozole—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.000327	CcSEcCtD
Letrozole—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000153	0.000326	CcSEcCtD
Letrozole—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.000326	CcSEcCtD
Letrozole—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000324	CcSEcCtD
Letrozole—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.00032	CcSEcCtD
Letrozole—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.00015	0.00032	CcSEcCtD
Letrozole—Oedema—Epirubicin—peripheral nervous system neoplasm	0.00015	0.00032	CcSEcCtD
Letrozole—Infection—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000317	CcSEcCtD
Letrozole—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000316	CcSEcCtD
Letrozole—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000313	CcSEcCtD
Letrozole—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.000313	CcSEcCtD
Letrozole—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000146	0.000312	CcSEcCtD
Letrozole—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000146	0.00031	CcSEcCtD
Letrozole—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000309	CcSEcCtD
Letrozole—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000308	CcSEcCtD
Letrozole—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000308	CcSEcCtD
Letrozole—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000308	CcSEcCtD
Letrozole—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000307	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000306	CcSEcCtD
Letrozole—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000305	CcSEcCtD
Letrozole—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000305	CcSEcCtD
Letrozole—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000302	CcSEcCtD
Letrozole—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000296	CcSEcCtD
Letrozole—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000296	CcSEcCtD
Letrozole—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000294	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000291	CcSEcCtD
Letrozole—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.00029	CcSEcCtD
Letrozole—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000289	CcSEcCtD
Letrozole—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.000289	CcSEcCtD
Letrozole—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.000287	CcSEcCtD
Letrozole—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000287	CcSEcCtD
Letrozole—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000286	CcSEcCtD
Letrozole—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000285	CcSEcCtD
Letrozole—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000284	CcSEcCtD
Letrozole—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000282	CcSEcCtD
Letrozole—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000281	CcSEcCtD
Letrozole—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000278	CcSEcCtD
Letrozole—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000276	CcSEcCtD
Letrozole—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000276	CcSEcCtD
Letrozole—Pain—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000273	CcSEcCtD
Letrozole—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000273	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000269	CcSEcCtD
Letrozole—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000267	CcSEcCtD
Letrozole—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000266	CcSEcCtD
Letrozole—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000264	CcSEcCtD
Letrozole—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000263	CcSEcCtD
Letrozole—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000263	CcSEcCtD
Letrozole—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000261	CcSEcCtD
Letrozole—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.00026	CcSEcCtD
Letrozole—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000257	CcSEcCtD
Letrozole—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000255	CcSEcCtD
Letrozole—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000255	CcSEcCtD
Letrozole—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000254	CcSEcCtD
Letrozole—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000253	CcSEcCtD
Letrozole—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000253	CcSEcCtD
Letrozole—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000253	CcSEcCtD
Letrozole—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000253	CcSEcCtD
Letrozole—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000244	CcSEcCtD
Letrozole—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000242	CcSEcCtD
Letrozole—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000235	CcSEcCtD
Letrozole—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000234	CcSEcCtD
Letrozole—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000234	CcSEcCtD
Letrozole—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000229	CcSEcCtD
Letrozole—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000226	CcSEcCtD
Letrozole—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000219	CcSEcCtD
Letrozole—Asthenia—Doxorubicin—peripheral nervous system neoplasm	9.95e-05	0.000212	CcSEcCtD
Letrozole—Dizziness—Epirubicin—peripheral nervous system neoplasm	9.91e-05	0.000211	CcSEcCtD
Letrozole—Pruritus—Doxorubicin—peripheral nervous system neoplasm	9.81e-05	0.000209	CcSEcCtD
Letrozole—Vomiting—Epirubicin—peripheral nervous system neoplasm	9.53e-05	0.000203	CcSEcCtD
Letrozole—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	9.49e-05	0.000202	CcSEcCtD
Letrozole—Rash—Epirubicin—peripheral nervous system neoplasm	9.45e-05	0.000201	CcSEcCtD
Letrozole—Dermatitis—Epirubicin—peripheral nervous system neoplasm	9.44e-05	0.000201	CcSEcCtD
Letrozole—Headache—Epirubicin—peripheral nervous system neoplasm	9.39e-05	0.0002	CcSEcCtD
Letrozole—Dizziness—Doxorubicin—peripheral nervous system neoplasm	9.17e-05	0.000196	CcSEcCtD
Letrozole—Nausea—Epirubicin—peripheral nervous system neoplasm	8.9e-05	0.00019	CcSEcCtD
Letrozole—Vomiting—Doxorubicin—peripheral nervous system neoplasm	8.82e-05	0.000188	CcSEcCtD
Letrozole—Rash—Doxorubicin—peripheral nervous system neoplasm	8.74e-05	0.000186	CcSEcCtD
Letrozole—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	8.74e-05	0.000186	CcSEcCtD
Letrozole—Headache—Doxorubicin—peripheral nervous system neoplasm	8.69e-05	0.000185	CcSEcCtD
Letrozole—Nausea—Doxorubicin—peripheral nervous system neoplasm	8.24e-05	0.000176	CcSEcCtD
